145 related articles for article (PubMed ID: 30787977)
1. Active surveillance for young patients with insular thyroid cancer: an initial and novel finding.
Liu Z; Zeng W; Zhou L; Zhou W; Chen D; Feng H; Wei W; Zhang C; Wang M; Guo L
Am J Transl Res; 2019; 11(1):176-187. PubMed ID: 30787977
[TBL] [Abstract][Full Text] [Related]
2. Propensity score matching analysis of the prognosis for the rare insular subtype of thyroid cancer based on SEER database.
Liu Y; Liu Z; Zhao Q; Hua T; Chi S; Huang T; Wang H
Oncotarget; 2017 Nov; 8(60):101623-101633. PubMed ID: 29254191
[TBL] [Abstract][Full Text] [Related]
3. Survival with Follicular and Hurthle Cell Microcarcinoma Compared to Papillary Thyroid Microcarcinoma: A Population Study of 84,532 Patients.
Khokar AM; Holoubek SA; Kuchta KM; Winchester DJ; Prinz RA; Moo-Young TA
World J Surg; 2020 Feb; 44(2):469-478. PubMed ID: 31863140
[TBL] [Abstract][Full Text] [Related]
4. Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching.
Liu Z; Zhao Q; Liu C; Zeng W; Ming J; Chen C; Wang S; Xiong Y; Zhang C; Chen T; Huang T; Guo L
Medicine (Baltimore); 2018 Aug; 97(31):e11791. PubMed ID: 30075609
[TBL] [Abstract][Full Text] [Related]
5. Do patients with oxyphilic cell papillary thyroid carcinoma have a poor prognosis? Analysis of the surveillance, epidemiology, and end results database 2004-2013 with propensity score matching.
Liu C; Zhao Q; Zeng W; Chen C; Ming J; Wang S; Xiong Y; Zhang C; Chen T; Liu Z; Huang T
Oncotarget; 2017 Sep; 8(44):77075-77085. PubMed ID: 29100371
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database.
Bi J; Lyu PF; Wang Y; Zhang H
Front Oncol; 2023; 13():1185650. PubMed ID: 37361590
[TBL] [Abstract][Full Text] [Related]
7. Insular thyroid cancer: a population-level analysis of patient characteristics and predictors of survival.
Kazaure HS; Roman SA; Sosa JA
Cancer; 2012 Jul; 118(13):3260-7. PubMed ID: 22252610
[TBL] [Abstract][Full Text] [Related]
8. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
[No Abstract] [Full Text] [Related]
9. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
[TBL] [Abstract][Full Text] [Related]
10. Unanticipated prognosis of differential thyroid cancer patients with T0 stage: analysis of the SEER database 2004-2013.
Liu C; Ming J; Zeng W; Wang S; Xiong Y; Zhao Q; Yin X; Liu Z; Huang T
Oncotarget; 2017 Sep; 8(41):70777-70787. PubMed ID: 29050318
[TBL] [Abstract][Full Text] [Related]
11. High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.
Kim HI; Jang HW; Ahn HS; Ahn S; Park SY; Oh YL; Hahn SY; Shin JH; Kim JH; Kim JS; Chung JH; Kim TH; Kim SW
J Clin Endocrinol Metab; 2018 Feb; 103(2):446-451. PubMed ID: 29211863
[TBL] [Abstract][Full Text] [Related]
12. Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis.
Liu C; Chen T; Zeng W; Wang S; Xiong Y; Liu Z; Huang T
Sci Rep; 2017 Sep; 7(1):11412. PubMed ID: 28900207
[TBL] [Abstract][Full Text] [Related]
13. Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.
Lin DZ; Qu N; Shi RL; Lu ZW; Ji QH; Wu WL
Onco Targets Ther; 2016; 9():5307-16. PubMed ID: 27601922
[TBL] [Abstract][Full Text] [Related]
14. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
Yang F; Zhong Q; Huang Z; Lian M; Fang J
Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
[No Abstract] [Full Text] [Related]
15. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
16. Mixed subtype thyroid cancer: A surveillance, epidemiology, and end results database analysis.
Liu C; Zhao Q; Li Z; Wang S; Xiong Y; Liu Z; Huang T
Oncotarget; 2017 Oct; 8(49):86556-86565. PubMed ID: 29156816
[TBL] [Abstract][Full Text] [Related]
17. [Surgery of papillary thyroid microcarcinoma].
Weber T; Peth S; Hummel R
Chirurg; 2018 Jun; 89(6):415-421. PubMed ID: 29305632
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of patients with TX stage differentiated thyroid cancer: propensity scored matching analysis of the SEER database 2004-2013.
Xiong Y; Zhao Q; Liu C; Wang S; Liu Z; Huang T
Am J Transl Res; 2018; 10(7):2004-2014. PubMed ID: 30093938
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of FTC compared to PTC and FVPTC: findings based on SEER database using propensity score matching analysis.
Liu Z; Zeng W; Huang L; Wang Z; Wang M; Zhou L; Chen D; Feng H; Zhou W; Guo L
Am J Cancer Res; 2018; 8(8):1440-1448. PubMed ID: 30210915
[TBL] [Abstract][Full Text] [Related]
20. [Risk Factors of Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma:An Analysis Based on Data from the Surveillance, Epidemiology and End Results Database].
Zheng KS; Zeng Y; Chen C; Wu YZ; Chen B; Ying WB; Zheng KW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):736-743. PubMed ID: 30606382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
